These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 32147297)

  • 41. Adverse events following immunization: is this time for the use of WHO causality assessment?
    Tafuri S; Gallone MS; Calabrese G; Germinario C
    Expert Rev Vaccines; 2015 May; 14(5):625-7. PubMed ID: 25805053
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sequential inactivated (IPV) and live oral (OPV) poliovirus vaccines for preventing poliomyelitis.
    Ciapponi A; Bardach A; Rey Ares L; Glujovsky D; Cafferata ML; Cesaroni S; Bhatti A
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD011260. PubMed ID: 31801180
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Causality assessment of adverse events following immunization: the problem of multifactorial pathology.
    Bellavite P
    F1000Res; 2020; 9():170. PubMed ID: 32269767
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Understanding the role of human variation in vaccine adverse events: the Clinical Immunization Safety Assessment Network.
    LaRussa PS; Edwards KM; Dekker CL; Klein NP; Halsey NA; Marchant C; Baxter R; Engler RJ; Kissner J; Slade BA
    Pediatrics; 2011 May; 127 Suppl 1():S65-73. PubMed ID: 21502239
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Surveillance of adverse events following immunisation: Australia 2002 to 2003.
    Lawrence G; Boyd I; McIntyre P; Isaacs D
    Commun Dis Intell Q Rep; 2004; 28(3):324-38. PubMed ID: 15574056
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Surveillance of adverse events following immunisation: Australia, 2000-2002.
    Lawrence G; Menzies R; Burgess M; McIntyre P; Wood N; Boyd I; Purcell P; Isaacs D
    Commun Dis Intell Q Rep; 2003; 27(3):307-23. PubMed ID: 14510057
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Safety Monitoring of mRNA COVID-19 Vaccines in Children Aged 5 to 11 Years by Using EudraVigilance Pharmacovigilance Database: The CoVaxChild Study.
    Zinzi A; Gaio M; Liguori V; Ruggiero R; Tesorone M; Rossi F; Rafaniello C; Capuano A
    Vaccines (Basel); 2023 Feb; 11(2):. PubMed ID: 36851276
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Adverse drug reactions following immunization in Germany pursuant to the German Infection Protection Act and the German Medicinal Products Act from January 1, 2004 to December 31, 2005].
    Weisser K; Meyer C; Petzold D; Mentzer D; Keller-Stanislawski B
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2007 Nov; 50(11):1404-17. PubMed ID: 17999134
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Allergic reactions to Japanese encephalitis vaccine.
    Plesner AM
    Immunol Allergy Clin North Am; 2003 Nov; 23(4):665-97. PubMed ID: 14753386
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Surveillance system for adverse events following immunization against yellow fever in Burkina Faso in 2008. Good practice recommendations].
    Yaméogo TM; Breugelmans JG; Kambou JL; Badolo O; Tiendrebéogo S; Traoré E; Avokey F; Yactayo S
    Med Trop (Mars); 2009 Aug; 69(4):320-1. PubMed ID: 19725376
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Adverse events following immunization and causality assessment of an adverse event following immunization].
    Yao KH; Yang YH
    Zhongguo Dang Dai Er Ke Za Zhi; 2014 Jan; 16(1):1-4. PubMed ID: 24461168
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Potential immediate hypersensitivity reactions following immunization in preschool aged children in Victoria, Australia.
    Baxter CM; Clothier HJ; Perrett KP
    Hum Vaccin Immunother; 2018; 14(8):2088-2092. PubMed ID: 29624467
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Safety monitoring in vaccine development and immunization.
    Lee CJ; Lee LH; Lu CH; Huang YJ; Chu ML
    Acta Paediatr Taiwan; 2006; 47(1):7-13. PubMed ID: 17016963
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Annual report: Surveillance of adverse events following immunisation in Australia, 2005.
    Lawrence G; Boyd I; McIntyre P; Isaacs D
    Commun Dis Intell Q Rep; 2006; 30(3):319-33. PubMed ID: 17120485
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Disease-related adverse events following non-live vaccines: investigation of a newly described reporting bias through the analysis of the WHO Global ICSR Database, VigiBase.
    Roberto G; Zanoni G
    Vaccine; 2014 May; 32(26):3328-35. PubMed ID: 24291198
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Adverse events following immunization in patients with primary immunodeficiencies.
    Sarmiento JD; Villada F; Orrego JC; Franco JL; Trujillo-Vargas CM
    Vaccine; 2016 Mar; 34(13):1611-1616. PubMed ID: 26850760
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The "Fluad Case" in Italy: Could it have been dealt differently?
    Levi M; Sinisgalli E; Lorini C; Santomauro F; Chellini M; Bonanni P
    Hum Vaccin Immunother; 2017 Feb; 13(2):379-384. PubMed ID: 27924687
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pediatric deaths reported after vaccination: the utility of information obtained from parents.
    Silvers LE; Varricchio FE; Ellenberg SS; Krueger CL; Wise RP; Salive ME
    Am J Prev Med; 2002 Apr; 22(3):170-6. PubMed ID: 11897461
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Adverse drug reactions during hepatitis C treatment with direct-acting antivirals: The role of medication errors, their impact on treatment discontinuation and their preventability. New insights from the Campania Region (Italy) spontaneous reporting system.
    Sessa M; Bernardi FF; Vitale A; Schiavone B; Gritti G; Mascolo A; Bertini M; Scavone C; Sportiello L; Rossi F; Capuano A
    J Clin Pharm Ther; 2018 Dec; 43(6):867-876. PubMed ID: 30014479
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Revised World Health Organization (WHO)'s causality assessment of adverse events following immunization-a critique.
    Puliyel J; Naik P
    F1000Res; 2018; 7():243. PubMed ID: 30026925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.